Animesh Pardanani Selected Research

Mast-Cell Leukemia (Leukemia, Mast Cell)

1/2022	Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
11/2018	Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models.
1/2002	Immunohistochemical studies of c-kit, transforming growth factor-beta, and basic fibroblast growth factor in mast cell disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Animesh Pardanani Research Topics

Disease

44	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 05/2002
38	Neoplasms (Cancer) 01/2022 - 02/2002
18	Systemic Mastocytosis 01/2022 - 11/2002
17	Eosinophilia 01/2020 - 05/2002
14	Leukemia 02/2019 - 01/2002
14	Essential Thrombocythemia 01/2019 - 05/2008
14	Polycythemia Vera 11/2016 - 10/2004
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2004
11	Splenomegaly 10/2021 - 04/2003
11	Anemia 02/2019 - 06/2008
10	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2018 - 05/2002
9	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 02/2010
6	Pdgfra-Associated Chronic Eosinophilic Leukemia 10/2018 - 06/2004
6	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2008 - 05/2004
5	Thrombocytopenia (Thrombopenia) 02/2019 - 04/2011
5	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 06/2004
5	Thrombosis (Thrombus) 01/2019 - 10/2010
5	Cytopenia 01/2018 - 04/2003
4	Pruritus (Itching) 06/2016 - 05/2004
3	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2022 - 01/2002
3	Polycythemia (Erythrocytosis) 12/2021 - 01/2021
3	Fibrosis (Cirrhosis) 05/2017 - 11/2002
3	Chronic Neutrophilic Leukemia 07/2015 - 04/2006
3	Mastocytosis 04/2013 - 10/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2011 - 10/2009
2	Abnormal Karyotype 01/2022 - 01/2012
2	Hemoglobinopathies 12/2021 - 05/2018
2	primary familial and congenital Polycythemia 01/2021 - 05/2018
2	Blast Crisis (Blast Phase) 01/2021 - 01/2018
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021 - 03/2003
2	Pathologic Complete Response 01/2021 - 01/2018
2	Neutropenia 02/2019 - 09/2015
2	Infections 01/2019 - 01/2013
2	Philadelphia Chromosome 05/2016 - 06/2008
2	Thrombocytosis (Thrombocythemia) 02/2013 - 11/2012
2	Leukocytosis (Pleocytosis) 11/2012 - 04/2011
2	Immunoglobulin Light-chain Amyloidosis 03/2010 - 02/2003
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2008 - 06/2007
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2008 - 08/2007
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2008 - 08/2007
2	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2004 - 01/2002
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 10/2021

Drug/Important Bio-Agent (IBA)

12	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019 - 05/2008
12	Imatinib Mesylate (Gleevec)FDA Link 02/2010 - 05/2002
11	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2003
11	CytokinesIBA 01/2022 - 02/2002
10	Pharmaceutical PreparationsIBA 01/2019 - 05/2002
9	Janus Kinase InhibitorsIBA 10/2021 - 03/2011
8	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2020 - 11/2003
7	CalreticulinIBA 01/2019 - 08/2014
6	ruxolitinibIBA 01/2022 - 10/2011
6	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2010 - 05/2003
5	Cladribine FDA LinkGeneric 01/2022 - 03/2003
5	DNA (Deoxyribonucleic Acid)IBA 02/2019 - 05/2009
4	venetoclaxIBA 10/2022 - 12/2020
4	fedratinibIBA 01/2022 - 03/2011
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 11/2003
4	Tryptases (Tryptase)IBA 10/2018 - 10/2003
4	Janus Kinase 2IBA 05/2016 - 12/2006
4	Phosphotransferases (Kinase)IBA 07/2011 - 05/2003
3	Oxygen (Dioxygen)IBA 12/2021 - 05/2018
3	Erythropoietin FDA Link 11/2018 - 06/2008
3	Alkaline PhosphataseIBA 11/2018 - 11/2002
3	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2018 - 03/2011
3	Interferon-alpha (Interferon Alfa)IBA 04/2015 - 12/2009
3	Interleukin-12 (IL 12)IBA 11/2012 - 04/2011
3	Interleukin-8 (Interleukin 8)IBA 02/2012 - 04/2011
3	Alemtuzumab (Campath)FDA Link 01/2012 - 01/2009
3	Prednisone (Sone)FDA LinkGeneric 01/2012 - 04/2003
3	Thalidomide (Thalomid)FDA Link 01/2011 - 04/2003
2	midostaurinIBA 01/2022 - 01/2022
2	4-hexyloxyaniline (HOA)IBA 12/2021 - 05/2018
2	Decitabine FDA Link 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 04/2012
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 01/2019
2	HematinicsIBA 01/2021 - 02/2011
2	CreatinineIBA 02/2019 - 08/2015
2	Busulfan (Busulfex)FDA Link 01/2019 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 03/2008
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2017 - 05/2017
2	Reticulin (Reticular Fiber)IBA 05/2017 - 11/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 04/2015
2	Ferritins (Ferritin)IBA 04/2013 - 05/2009
2	Biomarkers (Surrogate Marker)IBA 04/2012 - 04/2008
2	pomalidomideIBA 01/2012 - 04/2011
2	Tyrosine (L-Tyrosine)FDA Link 07/2011 - 05/2003
2	Interleukin-15 (Interleukin 15)IBA 04/2011 - 04/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2011 - 05/2003
2	Tyrosine Kinase InhibitorsIBA 10/2009 - 08/2007
2	Dasatinib (BMS 354825)FDA Link 06/2008 - 08/2007
2	Core Binding Factors (Core-Binding Factor)IBA 01/2008 - 08/2007
1	Sodium-Glucose Transport ProteinsIBA 12/2021
1	Testosterone (Sustanon)FDA Link 01/2021

Therapy/Procedure

42	Therapeutics 01/2022 - 03/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
4	Splenectomy 01/2019 - 02/2011
3	Induction Chemotherapy 10/2022 - 06/2013
2	Radiotherapy 01/2018 - 11/2017
2	Stem Cell Transplantation 11/2016 - 03/2015